+
Site Tour

EuroEcho 2021: Advances to optimize tricuspid regurgitation management: the evidence

Maurizio Taramasso presents on the clinical and real-world outcomes from the TRILUMINATE trial and TriClip™ bRIGHT study, respectively.

Related Videos

M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks

PCRLV 2021: Transcatheter mitral valve replacement

PCRLV 2021: MR & TR Clip Therapies

PCRLV 2022: TAVI Hemodynamic performance

Navitor™: Voice of the Experts Dave Smith

Navitor™: Voice of the Experts Dave Smith

TAVI Summit - PreTAVR CT analysis

TAVI 2023: Optimizing TAVI

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

EXPAND Study: Data overview

Tendyne™: 6-Year Outcomes

EuroPCR 2022: TAVI 1yr outcomes

EuroEcho 2021: MR Treatment (Patient)

CONNEXT


LIVE
RELATED EVENTS

SAFETY IS A JOURNEY | X. Freixa & F. Castriota

AV VALVES 2023: TA, TF in TMVR

TAVI 2023: Optimizing TAVI

Screening Transmission | Mitral focus

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline